Eugenia Poliakov

Staff scientist
Molecular Mechanisms Section
National Eye Institute
United States of America

Scientist Ophthalmology
Biography

Eugenia Poliakov has completed her Ph.D. in chemistry at the age of 26 years from Case Western Reserve University and Postdoctoral studies from National Eye Institute, NIH. From 2006 to present she is a Staff Scientist at Laboratory of Retinal Molecular and Cell Biology, NEI, NIH. She has published more than 20 papers in per-reviewed journals.

Research Intrest

Ophthalmology, Molecular Biology, Biochemistry, Catalysis and Bioinformatics

List of Publications
Samuel W, Jaworski C, Postnikova OA, Kutty RK, Duncan T, Tan LX, Poliakov E, Lakkaraju A, Redmond TM. Appropriately differentiated ARPE-19 cells regain phenotype and gene expression profiles similar to those of native RPE cells. Molecular Vision. 2017;23:60.
Rogozin IB, Pavlov YI, Goncearenco A, De S, Lada AG, Poliakov E, Panchenko AR, Cooper DN. Mutational signatures and mutable motifs in cancer genomes. Briefings in Bioinformatics. 2017 May 11.
Poliakov E, Samuel W, Duncan T, Gutierrez DB, Mata NL, Redmond TM. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl] retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl) retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1. PloS one. 2017 Apr 27;12(4):e0176487.